Cell Reports · 2013 · 98 citations · 41 references
Life SciencesBiochemistryMolecular BiologyCellular MetabolismMetabolismNeoplasiaHereditary Renal DiseasesKidney CancerMetabolic Pathway DefectsMitochondrial MetabolismUrea CycleUrea Cycle DisordersArginine MetabolismCytosolic Urea CycleFumarate Hydratase DeficiencyFumarate MetabolismHereditary LeiomyomatosisHereditary Renal CancerRenal Metabolic DisordersTherapeutic Target Identification
The identification of mutated metabolic enzymes in hereditary cancer syndromes has established a direct link between metabolic dysregulation and cancer. Mutations in the Krebs cycle enzyme, fumarate hydratase (FH), predispose affected individuals to leiomyomas, renal cysts, and cancers, though the respective pathogenic roles of mitochondrial and cytosolic FH isoforms remain undefined. On the basis of comprehensive metabolomic analyses, we demonstrate that FH1-deficient cells and tissues exhibit defects in the urea cycle/arginine metabolism. Remarkably, transgenic re-expression of cytosolic FH ameliorated both renal cyst development and urea cycle defects associated with renal-specific FH1 deletion in mice. Furthermore, acute arginine depletion significantly reduced the viability of FH1-deficient cells in comparison to controls. Our findings highlight the importance of extramitochondrial metabolic pathways in FH-associated oncogenesis and the urea cycle/arginine metabolism as a potential therapeutic target.
41
Otto Warbürg · Science · 1956 · 13.3K citations
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
Lenny Dang, David W. White, Bryson D. Bennett et al. · Nature · 2009 · 4.1K citations · Full text
HMDB: the Human Metabolome Database
David S. Wishart, Dorit Tzur, Craig Knox et al. · Nucleic Acids Research · 2007 · 3.3K citations · Full text